Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-17

Clinical Trial Update: PATH (Peer Advanced Training in Harm Reduction) to Reducing Burnout Among Peers Who Deliver Harm Reduction Services (R61 Phase Pilot) [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 PATH pilot aimed at reducing burnout and secondary traumatic stress among peers delivering harm-reduction service…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chestnut Health Systems | Conditions: Burnout, Compassion Satisfaction | Phase 2 | Status: ENROLLING_BY_INVITATION